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Memory retrievalIndividuals with epilepsy often complain about memory deficits. Various synthetic derivatives of natural
flavonoids are known to have neuroactive properties. Rutin is a flavonoid that is an important dietary
constituent of foods and plant-based beverages. The aim of the present study was to investigate the effects of
rutin on memory retrieval in pentylenetetrazole (PTZ)-kindled rats using a step-through passive avoidance
task. We administered rutin and PTZ intraperitoneally every other day prior to the start of training. Two
retention tests were subsequently performed to assess memory in these rats. The results suggest that
pretreatment with rutin at 50 and 100 mg/kg can attenuate seizure severity during the kindling procedure.
Furthermore, rutin administration significantly increased the step-through latency in the passive avoidance
paradigm. Taken together, these results indicate that rutin has a potential role in enhancing memory
retrieval in kindled rats., Qazvin University of Medical
2813324940.
assiri-Asl).
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Animal models for kindling provide an acceptable approach to
quantifying epileptogenesis [1]. Kindling induced with the convulsant
pentylenetetrazole (PTZ) represents a model of primary generalized
epilepsy [2,3]. The effects of epilepsy on cognition have been reviewed
in several articles [4–6], suggesting the presence of at least a mild
decline in intellectual performance in children and adults with
epilepsy [4]. However, correlating seizures with mental decline
requires a careful investigation of the types and frequencies of
seizures [5]. Patients with localized epilepsies generally have specific
deficits in the cognitive functions controlled by the respective areas,
for example, memory impairment associated with temporal lobe
epilepsy (TLE) [6]. The PTZ kindlingmodel provides a useful model for
postseizure dysfunction, serving as a screen for potential treatments
for the cognitive and emotional deficits that are observed in human
epilepsy [7]. There are several pieces of evidence for PTZ kindling-
induced impairment in shuttle-box performance tasks [8–13].On the other hand, several studies have shown that flavonoids and
other fruit- and vegetable-derived phytochemicals have beneficial
effects on learning and memory [14]. Several flavonoid-rich foods
including gingko biloba, green tea, blueberry, and pomegranate juice
have been shown to enhance neurocognitive ability in rodents [15–
18]. Rodent models have also been used to study human declarative
memory, predicting the potential effects of flavonoids on human
cognitive performance [19]. In addition, previous reports have
established a role for flavonoids in preventing dementia in humans
[20].
Rutin (3, 3′, 4′, 5, 7-pentahydroxyflavone-3-rhamnoglucoside) is a
flavonoid of the flavonol type that is an important dietary constituent
of foods and plant-based beverages [21]. Rutin has several noteworthy
pharmacological properties, including antioxidant, anticarcinogenic,
cytoprotective, antiplatelet, antithrombic, vasoprotective, cardiopro-
tective, and neuroprotective activities [22–28]. Furthermore, it acts as
an anticonvulsant in rats treated with PTZ [29], and has ameliorated
ischemia–reperfusion injury in the brain [30]. Recently, we found that
rutin may enhance memory retrieval in normal animals [31] and that
prolonged supplementation with rutin significantly reverses tri-
methyltin (TMT)-induced spatial memory impairments and damage
to pyramidal neurons in the hippocampal CA3b region. These effects
could potentially be related to the antioxidative effects of rutin [32] as
well as to suppressed microglial activation and pro-inflammatory
cytokines [33]. Thus, in this study, we focused on the possible effects
of rutin on memory retrieval in PTZ-kindled rats.
Fig. 1. Effects of repeated administration of rutin (10, 50, and 100 mg/kg) on the
development of PTZ-induced kindling (35 mg/kg, ip, 13 injections total), compared
with control. Data represent mean seizure stages±SEM, n=10.
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2.1. Animals
Male Wistar rats (200–250 g) were obtained from the Razi
Institute (Karaj, Iran) and housed in groups of four per cage under
standard laboratory conditions. They were kept at a constant room
temperature (21±2 °C) under a normal 12 L:12D regimen with free
access to food and water. Behavioral observations and evaluations
were performed by experimenters who were unaware of the
pharmacological treatment. All animal experiments were carried out
in accordance with the European Communities Council Directive of 24
November 1986 (86/609/EEC) in such a way as to minimize the
number of animals and their suffering.
2.2. Drugs
Rutin and PTZ were purchased from Sigma and were dissolved in
physiological saline prior to the experiments. All drugs were
administrated intraperitoneally (ip).
2.3. Experimental procedure
Rats were divided into four groups, each with 10 animals. In the
control group, salinewas injected 30 minutes before administration of
PTZ every other day (35 mg/kg, ip, 13 injections total).
After each injection, the animals were placed individually in plastic
boxes. Convulsive behavior was recorded for 20 minutes, and
behavioral changes were scored according to Racine's criteria [34]:
0=no behavioral changes; 1=facial movements, ear and facial
twitching; 2=myoclonic convulsions without rearing; 3=myoclonic
convulsions with rearing; 4=clonic convulsions with loss of posture;
5=generalized tonic–clonic seizures. In the remaining three groups
10, 50, or 100 mg/kg of rutin was administered 30 minutes before PTZ
every other day (35 mg/kg, ip, 13 injections total).
Furthermore, for memory testing, a group of animals with
unimpaired memory (because they had been injected with saline
instead of PTZ) were used. This groupwas used to elucidate the effects
of rutin on memory under baseline conditions, compared with levels
that were lower or higher than baseline.
2.4. Passive avoidance apparatus
Forty-eight hours after the last PTZ injection to induce kindling,
the animals were tested for learning behavior using a passive
avoidance shuttle-box task [35]. The learning box consisted of two
compartments, one light (white compartment, 20×20×30 cm) and
the other dark (black compartment, 20×20×30 cm). A guillotine
door opening (6×6 cm) was made on the floor in the center of the
partition between the two compartments. Stainless-steel grids (5 mm
in diameter) were placed at 1-cm intervals (distance between the
centers of grids) on the floor of the dark compartment to produce the
foot shock.
2.5. Training
All of the animals were allowed to habituate in the experimental
room for at least 30 minutes prior to the experiments. After
habituation, each animal was gently placed in the light compartment
of the apparatus; after 5 seconds, the guillotine door was opened and
the animal was allowed to enter the dark compartment. The latency to
the animal's entry into the dark compartment was recorded. Animals
that waited more than 100 seconds to cross into the dark compart-
ment were eliminated from the experiments. Once the animal crossed
with all four paws into the next compartment, the guillotine door was
closed and the rat was returned to its home cage.The acquisition trial was carried out 30 minutes after the
habituation trial. The animal was placed in the light compartment,
the guillotine door was opened 5 seconds later, and as soon as the
animal crossed into the dark compartment, the door was closed and a
footshock (50 Hz, 5 seconds, 0.2-mA intensity) was immediately
delivered to the grid floor of the dark room with an insulated
stimulator. After 20 seconds, the rat was removed from the apparatus
and placed in its home cage. Training was terminated when the rat
remained in the light compartment for 120 consecutive seconds [31].
2.6. Retention test
One and two days following training, the retention tests were
performed to evaluate memory. Each animal was placed in the light
compartment for 20 seconds, the door was opened, and the step-
through latency to entry into the dark compartment was measured.
The session ended either when the animal entered the dark
compartment or when it remained in the light compartment for
300 seconds. During these sessions, no electric shockwas applied [31].
2.7. Data analysis
The data were analyzed using a one-way ANOVA and the post hoc
Tukey test for multiple comparisons. A level of Pb0.05 was considered
significant.
3. Results
3.1. Effects of rutin pretreatment on kindling development
As shown in Fig. 1, the repeated application of 35 mg/kg PTZ
induced behavioral seizures of increasing severity, culminating in
clonic convulsions with loss of posture during stage 4 at the end of the
kindling procedure. Pretreatment with rutin (10, 50, and 100 mg/kg)
before each kindling injection modified the development of kindling.
Pretreatment with rutin at 10, 50, and 100 mg/kg significantly
reduced the mean seizure stage during the 13 kindling injections as
compared with the saline control (Pb0.01, Pb0.001, Pb0.001) (Fig. 1).
3.2. Effects of rutin pretreatment on passive avoidance test
Administration of rutin induced a significant increase in memory
retrieval on the first retention test (1 day after training) as compared
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30 minutes before the administration of PTZ every other day (35 mg/
kg, ip, 13 injections total) prior to training (Pb0.001) (Fig. 2). Rutin
also increased memory retrieval at a dose of 10 mg/kg; however, this
effect was not significant. Moreover, at 50 and 100 mg/kg, rutin
significantly increased memory retrieval in the second retention test
of the passive avoidance paradigm, compared with the control. This
effect was dose dependent (Pb0.01, Pb0.001) (Fig. 2).4. Discussion
A survey of more than 1000 patients with epilepsy in the United
States revealed that cognitive difficulties rank highest on a list of
potential concerns [36]. In humans, convulsive diseases such as
temporal lobe epilepsy (TLE) are often accompanied by impairments
in learning and memory [37]. Three forms of memory impairment
may occur among patients with epilepsy: (1) transient epileptic
amnesia, (2) accelerating long-term forgetting, and (3) remote
memory impairment [38].
In the present study, we investigated the effect of rutin on the
development of PTZ-induced kindling in rats. Pretreatment with rutin
at 50 and 100 mg/kg attenuated seizure severity from the beginning
of the kindling procedure by lowering the mean seizure stage.
Moreover, it appears that the effects of rutin at higher doses are more
significant.
Furthermore, pretreatment with rutin before administration of
PTZ every other day, and prior to training, is associatedwith enhanced
memory retrieval in rats. Rutin (50 and 100 mg/kg) significantly
increased retrieval of memory in the first and second retention tests of
a passive avoidance task, compared with controls. The cognitive-
enhancing effect of rutin was also observed at 10 mg/kg. The results
for the saline group suggest that rutin restored memory to a level
higher than baseline.
Several studies have demonstrated that flavonoids have neuroac-
tive properties [13,39,40] and that many of these compounds are
ligands for GABAA receptors in the central nervous system (CNS)
[41,42]. Furthermore, they have been found to act like benzodiazepine
[43–45]. These findings are supported by behavioral data measuring
anxiety, sedation, and convulsive activity in animal models [39,41,46].
In our previous study, intracerebroventricular (icv.) injection of rutin
affectedminimal clonic seizures (MCSs) in a dose-dependent manner,
as well as generalized tonic–clonic seizures (GTCSs), inducedwith PTZ
in rats [29]. The GABAergic system contributed to the anticonvulsant
activity of rutin in this study [29]. Moreover, administration of rutin
(10 mg/kg) 1 week before the start of training significantly increasedFig. 2. Effects of rutin (10, 50, and 100 mg/kg) on step-through latency in rats. Values
are expressed as means±SEM. The control group received PTZ injections every other
day (35 mg/kg, ip, 13 injections total) prior to the experiments. The three remaining
groups were given 10, 50, and 100 mg/kg rutin 30 minutes before administration of PTZ
every other day prior to the experiments. Retention tests were performed 1 and 2 days
after training, **Pb0.01, ***Pb0.001 compared with the same-day control, ##Pb0.01,
###Pb0.001 compared with the same-day saline group, n=10, Tukey–Kramer test.retrieval of memory in the first, second, and third retention tests of a
passive avoidance task, compared with controls [31]. Thus, it is
possible that by enhancing the activity of the GABAergic and opioid
systems, rutin can reduce the severity of seizures resulting from
kindling and enhance memory retrieval in kindled rats. However, in
this study, it appears that a higher dose of rutin is needed to enhance
memory retrieval in kindled rats than in normal rats.
Similar results have been observed in rats treated with rutin; both
rutin and quercetin improved spatial memory impairment, as
assessed with the eight-arm radial maze task, and reduced neuronal
death in the hippocampal CA1 area. The same study revealed that,
biochemically, the 4-oxo group and the 2,3 double bond in the C ring
common to both rutin and quercetin are related to their neuropro-
tective action. However, it was also demonstrated that rutin has a
more significant effect on spatial memory impairment than quercetin
[28]. It has already been established that the CA3 subregion of the
hippocampus plays an important role in the acquisition of contextual
memory, whereas the CA1 subregion plays a role in the consolidation
process [47].
Furthermore, the anti-inflammatory effects of flavonoids, includ-
ing rutin, have been reported in several studies. Their role in the
inhibition of nitric oxide production has also been discussed [48–51].
In another study, both rutin and quercetin were found to protect the
cell membrane from lipid oxidation, a result that was related to their
antioxidant effects [52]. Collectively, all of these mechanisms could
contribute to the cognition-enhancing effects of rutin.
The direct role of flavonoids in memory acquisition, consolidation,
and storage was described previously in a study that induced
activation of neuronal signaling and gene expression in the brain.
The results from this study indicate that this may lead to changes in
synaptic plasticity and neurogenesis in the brain, ultimately influ-
encing memory, learning, and cognition [53]. Flavonoids have been
shown to influence peripheral blood flow in humans [54]; for
example, in a brain imaging study, the consumption of flavanol-rich
cocoa enhanced cortical blood flow [55]. This result is important when
considering mechanisms that increase cerebrovascular function,
especially in the hippocampus, a brain region that is important for
memory and that may facilitate adult neurogenesis [56]. New
hippocampal cells cluster near the blood vessels; they proliferate in
response to vascular growth factors and may eventually influence
memory [57].
In recent years, several mechanisms for signaling pathways that
underlie improved cognitive function have been examined. Some
results suggest that flavonoids activate the extracellular signal-
regulated protein kinase–cAMP–response element-binding protein
(ERK-CREB) pathway and the phosphoinositide 3-kinase–mTOR (PI3-
kinase-mTOR) cascade, leading to changes in synaptic plasticity. They
are also capable of influencing neurogenesis through the activation of
PI3-kinase–Akt–eNOS [58]. It has been shown that quercetin fits into
the ATP-binding pocket of the PI3-kinase, inhibiting its activity. This
inhibitory action has been proposed as a potential mechanism by
which flavonoids modulate neuronal function [59]. Moreover,
flavonoids reportedly block oxidation-induced neuronal damage by
preventing the activation of caspase-3, thereby providing evidence in
support of their potent antiapoptotic action [60].
It has therefore been suggested that rutin not only blocks a
memory-destroying effect of kindling, but also has memory-enhanc-
ing effects, thereby enhancing memory retrieval in the passive
avoidance task.
In our study, pretreatment with rutin before administration of PTZ
every other day prior to training decreased the severity of seizures
and resulted in increased retrieval of memory, which was observed in
kindled rats during the first and second retention tests of the passive
avoidance task. This effect was more significant when rutin was
administered at doses of 50 and 100 mg/kg. Rutin may mediate
memory retrieval in a variety of ways. Further study is necessary to
53M. Nassiri-Asl et al. / Epilepsy and Behavior 18 (2010) 50–53evaluate the effect of rutin on retention of memory and to determine
the molecular mechanisms involved in this process.References
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